CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
Taking everything into account, CHR scores 5 out of 10 in our fundamental rating. CHR was compared to 8 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on CHR. This makes CHR very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CHR was profitable.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
Each year in the past 5 years CHR had a positive operating cash flow.
1.2 Ratios
CHR has a Return On Assets of -17.42%. This is in the lower half of the industry: CHR underperforms 62.50% of its industry peers.
CHR has a Return On Equity (-47.80%) which is in line with its industry peers.
CHR's Return On Invested Capital of 6.29% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 5.39%.
The last Return On Invested Capital (6.29%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
The Operating Margin of CHR (6.77%) is better than 62.50% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR (65.04%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
The number of shares outstanding for CHR has been increased compared to 5 years ago.
CHR has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.87, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a Altman-Z score of 0.87. This is in the lower half of the industry: CHR underperforms 62.50% of its industry peers.
The Debt to FCF ratio of CHR is 3.86, which is a good value as it means it would take CHR, 3.86 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.86, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.68 indicates that CHR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.68, CHR belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 0.87 |
ROIC/WACC0.74
WACC8.53%
2.3 Liquidity
A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
CHR has a better Current ratio (1.22) than 62.50% of its industry peers.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHR (0.71) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for CHR have decreased by -5.14% in the last year.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
CHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.15%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
CHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.82% yearly.
Based on estimates for the next years, CHR will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CHR is valuated correctly with a Price/Earnings ratio of 13.90.
Compared to the rest of the industry, the Price/Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 87.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CHR is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 11.30, the valuation of CHR can be described as reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CHR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.9 | ||
| Fwd PE | 11.3 |
4.2 Price Multiples
87.50% of the companies in the same industry are more expensive than CHR, based on the Enterprise Value to EBITDA ratio.
87.50% of the companies in the same industry are more expensive than CHR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.5 | ||
| EV/EBITDA | 5.12 |
4.3 Compensation for Growth
CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
CHR has a Yearly Dividend Yield of 1.41%.
CHR's Dividend Yield is comparable with the industry average which is at 2.90.
With a Dividend Yield of 1.41, CHR pays less dividend than the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.41% |
5.2 History
On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
CHR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-7.29%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
TSX:CHR (7/11/2025, 7:00:00 PM)
23.08
+0.32 (+1.41%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap596.62M
Analysts78.18
Price Target28.23 (22.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.41% |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)0%
PT rev (3m)1.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.7%
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.9 | ||
| Fwd PE | 11.3 | ||
| P/S | 0.43 | ||
| P/FCF | 5.5 | ||
| P/OCF | 3.99 | ||
| P/B | 1.16 | ||
| P/tB | 1.18 | ||
| EV/EBITDA | 5.12 |
EPS(TTM)1.66
EY7.19%
EPS(NY)2.04
Fwd EY8.85%
FCF(TTM)4.2
FCFY18.19%
OCF(TTM)5.78
OCFY25.05%
SpS53.95
BVpS19.97
TBVpS19.63
PEG (NY)0.22
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.87 |
F-Score6
WACC8.53%
ROIC/WACC0.74
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%